{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:19:19Z","timestamp":1792696759984,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ebiom.2021.103622","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T04:05:19Z","timestamp":1634875519000},"page":"103622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation"],"prefix":"10.1016","volume":"73","author":[{"given":"Benjamin","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Coupez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Adda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Saint-Sardos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Bereiziat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Laurichesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ebiom.2021.103622_bib0001","doi-asserted-by":"crossref","first-page":"1708\u201120","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103622_bib0002","doi-asserted-by":"crossref","first-page":"669\u201177","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019: a model-based analysis","volume":"20","author":"Verity","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10223","key":"10.1016\/j.ebiom.2021.103622_bib0003","doi-asserted-by":"crossref","first-page":"497\u2011506","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2021.103622_bib0004","article-title":"Palliative care in critically ill COVID-19 patients: the early New York City experience","author":"Sheehan","year":"2020","journal-title":"BMJ Support Palliat Care"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103622_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243269","article-title":"Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: a cohort study","volume":"15","author":"Socolovithc","year":"2020","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.ebiom.2021.103622_bib0006","doi-asserted-by":"crossref","first-page":"2052\u20119","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103622_bib0007","doi-asserted-by":"crossref","first-page":"1345\u201155","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in Intensive Care Units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103622_bib0008","doi-asserted-by":"crossref","first-page":"1958\u201164","DOI":"10.1080\/22221751.2020.1812437","article-title":"Risks and features of secondary infections in severe and critical ill COVID-19 patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"10229","key":"10.1016\/j.ebiom.2021.103622_bib0009","doi-asserted-by":"crossref","first-page":"1054\u201162","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"7821","key":"10.1016\/j.ebiom.2021.103622_bib0010","doi-asserted-by":"crossref","first-page":"463\u20119","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103622_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103622_bib0012","doi-asserted-by":"crossref","first-page":"910\u201141","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2021.103622_bib0013","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2021.103622_bib0014","first-page":"eabc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103622_bib0015","doi-asserted-by":"crossref","first-page":"1233\u201144","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103622_bib0016","doi-asserted-by":"crossref","first-page":"1152\u20114","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u00ab Cytokine Storm \u00bb relevant to COVID-19?","volume":"180","author":"Sinha","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ebiom.2021.103622_bib0017","article-title":"COVID-19: what type of cytokine storm are we dealing with?","author":"Monneret","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2021.103622_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell [Internet]"},{"key":"10.1016\/j.ebiom.2021.103622_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol [Internet]"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103622_bib0020","doi-asserted-by":"crossref","first-page":"345\u201153","DOI":"10.1111\/imm.13254","article-title":"Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection","volume":"161","author":"Peruzzi","year":"2020","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103622_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2021.103622_bib0022","article-title":"Myeloid cells in sepsis-acquired immunodeficiency","author":"Venet","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ebiom.2021.103622_bib0023","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103622_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3024","article-title":"Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm","author":"Mudd","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2021.103622_bib0025","article-title":"Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19","author":"Sims","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103622_bib0026","doi-asserted-by":"crossref","first-page":"669\u201180","DOI":"10.1007\/s00281-020-00827-8","article-title":"Control of immunity by glucocorticoids in health and disease","volume":"42","author":"Shimba","year":"2020","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ebiom.2021.103622_bib0027","article-title":"Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19","author":"Andreakos","year":"2020","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103622_bib0028","doi-asserted-by":"crossref","first-page":"862\u201174","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103622_bib0029","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/cc9184","article-title":"Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies","volume":"14","author":"Monneret","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.ebiom.2021.103622_bib0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2019.01147","article-title":"The CD14+HLA-DRlo\/neg monocyte: an immunosuppressive phenotype that restrains responses to cancer immunotherapy","volume":"10","author":"Mengos","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2021.103622_bib0031","doi-asserted-by":"crossref","unstructured":"Benlyamani I, Venet F, Coudereau R, Gossez M, Monneret G. Monocyte HLA-DR measurement by flow cytometry in COVID-19 patients: an interim review. Cytometry Part A [Internet]. [cited on Dec8, 2020] Available on: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cyto.a.24249","DOI":"10.1002\/cyto.a.24249"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103622_bib0032","first-page":"1769\u201171","article-title":"Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression","volume":"46","author":"Jeannet","year":"2020","journal-title":"Intensive Care Med sept"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103622_bib0033","doi-asserted-by":"crossref","first-page":"875\u20117","DOI":"10.1038\/s41423-020-0483-y","article-title":"Systemically comparing host immunity between survived and deceased COVID-19 patients","volume":"17","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103622_bib0034","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13054-020-02896-5","article-title":"COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients","volume":"24","author":"Kox","year":"2020","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103622_bib0035","doi-asserted-by":"crossref","first-page":"2341\u20117","DOI":"10.1373\/clinchem.2005.052639","article-title":"Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study","volume":"51","author":"D\u00f6cke","year":"2005","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103622_bib0036","doi-asserted-by":"crossref","first-page":"970\u20113","DOI":"10.1007\/s10875-020-00806-6","article-title":"Flow cytometry identifies risk factors and dynamic changes in patients with COVID-19","volume":"40","author":"Moratto","year":"2020","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103622_bib0037","doi-asserted-by":"crossref","first-page":"993\u20119","DOI":"10.1213\/ANE.0000000000005044","article-title":"Reduced monocytic human leukocyte antigen-dr expression indicates immunosuppression in critically Ill COVID-19 patients","volume":"131","author":"Spinetti","year":"2020","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103622_bib0038","doi-asserted-by":"crossref","first-page":"887\u201190","DOI":"10.1002\/cyto.a.24188","article-title":"Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection","volume":"97","author":"Gatti","year":"2020","journal-title":"Cytometry A"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103622_bib0039","doi-asserted-by":"crossref","first-page":"1144\u201151","DOI":"10.1164\/rccm.200309-1329OC","article-title":"Monocyte human leukocyte antigen\u2013DR transcriptional downregulation by cortisol during septic shock","volume":"169","author":"Le Tulzo","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103622_bib0040","doi-asserted-by":"crossref","first-page":"12\u20119","DOI":"10.1006\/cimm.1995.1181","article-title":"Modulation of MHC class II expression in human cells by dexamethasone","volume":"165","author":"Schwiebert","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ebiom.2021.103622_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580250","article-title":"A longitudinal study of immune cells in severe COVID-19 patients","volume":"11","author":"Payen","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103622_bib0042","doi-asserted-by":"crossref","first-page":"1764\u20115","DOI":"10.1007\/s00134-020-06123-1","article-title":"Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients","volume":"46","author":"Monneret","year":"2020","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103622_bib0043","doi-asserted-by":"crossref","first-page":"193\u20118","DOI":"10.1016\/j.imlet.2004.07.009","article-title":"The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration","volume":"95","author":"Monneret","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ebiom.2021.103622_bib0044","article-title":"Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?","author":"Mudd","year":"2020","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103622_bib0045","doi-asserted-by":"crossref","first-page":"1322\u201133","DOI":"10.1093\/infdis\/jiab065","article-title":"Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19","volume":"223","author":"Janssen","year":"2021","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103622_bib0046","doi-asserted-by":"crossref","first-page":"1475\u201182","DOI":"10.1164\/rccm.200203-217OC","article-title":"Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock","volume":"166","author":"Fumeaux","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103622_bib0047","doi-asserted-by":"crossref","first-page":"1846\u201158","DOI":"10.1111\/all.14746","article-title":"Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19","volume":"76","author":"Gu\u00e9ant","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ebiom.2021.103622_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103622_bib0049","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41598-021-82212-5","article-title":"Proteolytic cleavage of HLA class II by human neutrophil elastase in pneumococcal pneumonia","volume":"11","author":"Domon","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103622_bib0050","doi-asserted-by":"crossref","first-page":"846\u20118","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"17","key":"10.1016\/j.ebiom.2021.103622_bib0051","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2021.103622_bib0052","article-title":"Tocilizumab\u2019s efficacy in patients with Coronavirus Disease 2019 (COVID-19) is determined by the presence of cytokine storm","author":"Andrianopoulos","year":"2020","journal-title":"J Med Virol [Internet]"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:10:28Z","timestamp":1762456228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421004151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":52,"alternative-id":["S2352396421004151"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103622","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103622"}}